VX-445/Tezacaftor/Ivacaftor

VX-445/tezacaftor/ivacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-445/Tezacaftor/Ivacaftor, covering 2021-08-18 to 2021-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del [Phase 3]

See pricing